Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison [NA]

View source ↗

Summary

An ongoing study at Charité University in Berlin is evaluating oxytocin-augmented group psychotherapy for schizophrenia spectrum disorders, with dose comparison…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Schizophrenia Spectrum Disorders (SSD) | NA | Status: RECRUITING